FDA Drug Application (022511) for VIMOVO by HORIZON PHARMA USA

Back to FDA Applications sponsored by HORIZON PHARMA USA

Application Number022511
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
DosageEQ 20MG BASE;500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVIMOVO
Active IngredientESOMEPRAZOLE MAGNESIUM; NAPROXEN

Active IngredientCount
List of drugs with Active Ingredient ESOMEPRAZOLE MAGNESIUM5
List of drugs with Active Ingredient NAPROXEN8


Back to FDA Applications sponsored by HORIZON PHARMA USA